Kevin P. Siu
After eight years of protracted litigation, a patent battle over…
Read More
ai biologics biosimilars class actions competition copyright evidence fair dealing infringement insufficiency legislation methods of medical treatment overbreadth patentable subject matter patents pharmaceuticals privacy procedure regulatory TPMs trademarks